No, isosorbide mononitrate is not routinely indicated for CABG patients
Isosorbide mononitrate should NOT be prescribed routinely to all CABG patients. The 2011 ACCF/AHA CABG guidelines make no recommendation for routine nitrate therapy post-CABG 1. The guideline clearly specifies Class I recommendations for aspirin and statin therapy, but nitrates are conspicuously absent from post-CABG medical management protocols.
Core Post-CABG Medical Therapy
According to the definitive CABG guidelines, the mandatory medications are 1:
Class I (Must prescribe):
- Aspirin 100-325 mg daily (initiated within 6 hours postoperatively, continued indefinitely)
- Statin therapy (adequate dose to reduce LDL <100 mg/dL with ≥30% reduction)
Class IIa (Reasonable alternatives):
- Clopidogrel 75 mg daily (if aspirin intolerant/allergic)
When Nitrates May Be Considered
Isosorbide mononitrate has specific, limited indications post-CABG:
1. Radial Artery Graft Antispasm
If radial artery grafts were used, antispastic therapy is warranted. Recent evidence suggests:
- A 2025 pilot trial showed isosorbide mononitrate 50 mg daily reduced radial artery graft failure rates compared to diltiazem (12.5% vs 27.8% at 24 weeks) 2
- Historical data supports high-dose nitrates perioperatively for composite arterial grafts 3
- However, this is for radial artery grafts specifically, not routine CABG with saphenous vein grafts
2. Symptomatic Angina Despite Optimal Therapy
If the patient develops recurrent angina after CABG despite aspirin and statin therapy, then nitrates become appropriate for symptom management 4.
Critical Pitfalls to Avoid
Do not prescribe isosorbide mononitrate reflexively to CABG patients because:
No mortality/morbidity benefit: Unlike aspirin (which reduces mortality, MI, stroke, renal failure) and statins (which improve graft patency and outcomes), nitrates have no proven benefit for routine post-CABG patients 1
Potential harm in heart failure: Recent data shows isosorbide mononitrate actually decreased activity levels in heart failure patients with preserved ejection fraction 5
Tolerance development: Continuous nitrate exposure leads to tolerance, reducing efficacy 4
Hypotension risk: Particularly problematic in volume-depleted post-surgical patients 4
Practical Algorithm
For standard CABG (saphenous vein grafts):
- Aspirin + Statin = YES
- Isosorbide mononitrate = NO (unless symptomatic angina develops)
For CABG with radial artery grafts:
- Aspirin + Statin = YES
- Consider isosorbide mononitrate 50 mg daily for 24 weeks for graft protection 2
The evidence is clear: focus on aspirin and statins, which have proven Class I indications for improving graft patency and reducing adverse cardiovascular events post-CABG.